155 related articles for article (PubMed ID: 12766261)
1. Effect of transport inhibitors and additional anti-HIV drugs on the movement of lamivudine (3TC) across the guinea pig brain barriers.
Gibbs JE; Rashid T; Thomas SA
J Pharmacol Exp Ther; 2003 Sep; 306(3):1035-41. PubMed ID: 12766261
[TBL] [Abstract][Full Text] [Related]
2. The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig.
Anthonypillai C; Sanderson RN; Gibbs JE; Thomas SA
J Pharmacol Exp Ther; 2004 Mar; 308(3):912-20. PubMed ID: 14634041
[TBL] [Abstract][Full Text] [Related]
3. The transport of the anti-HIV drug, 2',3'-didehydro-3'-deoxythymidine (D4T), across the blood-brain and blood-cerebrospinal fluid barriers.
Thomas SA; Segal MB
Br J Pharmacol; 1998 Sep; 125(1):49-54. PubMed ID: 9776343
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which 2',3'-dideoxyinosine (ddI) crosses the guinea-pig CNS barriers; relevance to HIV therapy.
Gibbs JE; Jayabalan P; Thomas SA
J Neurochem; 2003 Feb; 84(4):725-34. PubMed ID: 12562517
[TBL] [Abstract][Full Text] [Related]
5. Transport characteristics of the anti-human immunodeficiency virus nucleoside analog, abacavir, into brain and cerebrospinal fluid.
Thomas SA; Bye A; Segal MB
J Pharmacol Exp Ther; 2001 Sep; 298(3):947-53. PubMed ID: 11504789
[TBL] [Abstract][Full Text] [Related]
6. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
7. The distribution of the anti-HIV drug, 2'3'-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors.
Gibbs JE; Thomas SA
J Neurochem; 2002 Feb; 80(3):392-404. PubMed ID: 11905988
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea transport across the blood-brain and blood-cerebrospinal fluid barriers of the guinea-pig.
Dogruel M; Gibbs JE; Thomas SA
J Neurochem; 2003 Oct; 87(1):76-84. PubMed ID: 12969254
[TBL] [Abstract][Full Text] [Related]
9. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.
Strazielle N; Khuth ST; Ghersi-Egea JF
Adv Drug Deliv Rev; 2004 Oct; 56(12):1717-40. PubMed ID: 15381331
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine uptake into the central nervous system of the Guinea pig: an in situ brain perfusion study.
Gibbs JE; Gaffen Z; Thomas SA
J Pharmacol Exp Ther; 2006 May; 317(2):746-51. PubMed ID: 16424147
[TBL] [Abstract][Full Text] [Related]
11. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.
Shen DD; Artru AA; Adkison KK
Adv Drug Deliv Rev; 2004 Oct; 56(12):1825-57. PubMed ID: 15381336
[TBL] [Abstract][Full Text] [Related]
12. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
13. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.
Kuo YC; Chen HH
Int J Pharm; 2006 Dec; 327(1-2):160-9. PubMed ID: 16939704
[TBL] [Abstract][Full Text] [Related]
14. The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.
Tachikawa M; Kasai Y; Takahashi M; Fujinawa J; Kitaichi K; Terasaki T; Hosoya K
J Neurochem; 2008 Oct; 107(2):432-42. PubMed ID: 18752646
[TBL] [Abstract][Full Text] [Related]
15. Circulating neuroactive peptides and the blood-brain and blood-cerebrospinal fluid barriers.
Zlokovic BV; Segal MB; Davson H; Lipovac MN; Hyman S; McComb JG
Endocrinol Exp; 1990 Mar; 24(1-2):9-17. PubMed ID: 2193795
[TBL] [Abstract][Full Text] [Related]
16. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
[TBL] [Abstract][Full Text] [Related]
17. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
[TBL] [Abstract][Full Text] [Related]
18. The involvement of the blood-brain and the blood-cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain.
Kurrimbux D; Gaffen Z; Farrell CL; Martin D; Thomas SA
Neuroscience; 2004; 123(2):527-36. PubMed ID: 14698759
[TBL] [Abstract][Full Text] [Related]
19. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse.
Banks WA; Goulet M; Rusche JR; Niehoff ML; Boismenu R
J Pharmacol Exp Ther; 2002 Sep; 302(3):1062-9. PubMed ID: 12183664
[TBL] [Abstract][Full Text] [Related]
20. Usefulness and limitation of primary cultured porcine choroid plexus epithelial cells as an in vitro model to study drug transport at the blood-CSF barrier.
Angelow S; Zeni P; Galla HJ
Adv Drug Deliv Rev; 2004 Oct; 56(12):1859-73. PubMed ID: 15381337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
